{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T22:41:54Z","timestamp":1790030514629,"version":"4.0.1"},"reference-count":26,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2004,12,1]],"date-time":"2004-12-01T00:00:00Z","timestamp":1101859200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2004,12,1]],"date-time":"2004-12-01T00:00:00Z","timestamp":1101859200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["dmd.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Metabolism and Disposition"],"published-print":{"date-parts":[[2004,12]]},"DOI":"10.1124\/dmd.104.001164","type":"journal-article","created":{"date-parts":[[2004,8,25]],"date-time":"2004-08-25T00:14:44Z","timestamp":1093392884000},"page":"1333-1336","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":63,"title":["MULTIPLE NIGHT-TIME DOSES OF VALERIAN (Valeriana officinalis) HAD MINIMAL EFFECTS ON CYP3A4 ACTIVITY AND NO EFFECT ON CYP2D6 ACTIVITY IN HEALTHY VOLUNTEERS"],"prefix":"10.1016","volume":"32","author":[{"given":"Jennifer L.","family":"Donovan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. Lindsay","family":"DeVane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth D.","family":"Chavin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun-Sheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryan B.","family":"Gibson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Holly A.","family":"Gefroh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John S.","family":"Markowitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/dmd.104.001164_bib1","first-page":"71","article-title":"Herbs continue slide in mainstream market: sales down 14 percent.","volume":"58","author":"Blumenthal","year":"2003","journal-title":"HerbalGram"},{"key":"10.1124\/dmd.104.001164_bib2","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0021-9673(02)00036-5","article-title":"Determination of valepotriates.","volume":"967","author":"Bos","year":"2002","journal-title":"J Chromatogr A"},{"key":"10.1124\/dmd.104.001164_bib3","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0944-7113(00)80044-6","article-title":"An in vitro evaluation of human cytochrome P450 3A4 inhibition by selected commercial herbal extracts and tinctures.","volume":"74","author":"Budzinski","year":"2000","journal-title":"Phytomedicine"},{"key":"10.1124\/dmd.104.001164_bib4","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s00210-003-0815-3","article-title":"Cytochrome P450 3A and their regulation.","volume":"369","author":"Burk","year":"2004","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"10.1124\/dmd.104.001164_bib5","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1124\/dmd.104.000083","article-title":"Green tea (Camellia sinensis) extract does not alter cytochrome P-450 3A4 or 2D6 activity in healthy volunteers.","volume":"32","author":"Donovan","year":"2004","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.104.001164_bib6","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1124\/dmd.31.5.519","article-title":"Siberian ginseng (Eleutherococcus senticosus) effects on CYP2D6 and CYP3A4 activity in normal volunteers.","volume":"31","author":"Donovan","year":"2003","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.104.001164_bib7","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1046\/j.0306-5251.2001.01469.x","article-title":"Herb-drug interactions: review and assessment of report reliability.","volume":"52","author":"Fugh-Berman","year":"2001","journal-title":"Br J Clin Pharmacol"},{"key":"10.1124\/dmd.104.001164_bib8","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0378-4347(97)00225-9","article-title":"Modified high-performance liquid chromatographic method to measure both dextromethorphan and proguanil for oxidative phenotyping.","volume":"696","author":"Hoskins","year":"1997","journal-title":"J Chromatogr B"},{"key":"10.1124\/dmd.104.001164_bib9","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1211\/0022357991772772","article-title":"The scientific basis for the reputed activity of Valerian.","volume":"51","author":"Houghton","year":"1999","journal-title":"J Pharm Pharmacol"},{"key":"10.1124\/dmd.104.001164_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.clpt.2003.07.002","article-title":"Drug interactions with herbal products and grapefruit juice: a conference report.","volume":"75","author":"Huang","year":"2004","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/dmd.104.001164_bib11","first-page":"1145","article-title":"How should we assess the effects of exposure to dietary polyphenols in vitro?","volume":"79","author":"Kroon","year":"2004","journal-title":"Am J Clin Nutr"},{"key":"10.1124\/dmd.104.001164_bib12","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1017\/S1092852900001668","article-title":"The use of valerian in neuropsychiatry.","volume":"6","author":"Krystal","year":"2001","journal-title":"CNS Spectrums"},{"key":"10.1124\/dmd.104.001164_bib13","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1097\/00004714-200204000-00010","article-title":"Differential time course of cytochrome P450 2D6 enzyme inhibition by fluoxetine, sertraline and paroxetine in healthy volunteers.","volume":"22","author":"Liston","year":"2002","journal-title":"J Clin Psychopharmacol"},{"key":"10.1124\/dmd.104.001164_bib14","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1097\/01.jcp.0000095340.32154.c6","article-title":"Multiple-dose administration of Ginkgo biloba did not affect cytochrome P450 2D6 or 3A4 activity in normal volunteers.","volume":"23","author":"Markowitz","year":"2003","journal-title":"J Clin Psychopharmacol"},{"key":"10.1124\/dmd.104.001164_bib15","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1001\/jama.290.11.1500","article-title":"Effect of St. John\u2019s wort on drug metabolism by induction of cytochrome P450 3A4 enzyme.","volume":"290","author":"Markowitz","year":"2003","journal-title":"J Am Med Assoc"},{"key":"10.1124\/dmd.104.001164_bib16","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/S0378-4347(00)83150-3","article-title":"Alprazolam, alpha-hydroxy and 4-hydroxyalprazolam analysis in plasma by high performance liquid chromatography.","volume":"430","author":"Miller","year":"1988","journal-title":"J Chromatogr B"},{"key":"10.1124\/dmd.104.001164_bib17","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1177\/001872089103300105","article-title":"Cognitive factors and the use of over-the-counter medication organizers by arthritis patients.","volume":"33","author":"Park","year":"1991","journal-title":"Hum Factors"},{"key":"10.1124\/dmd.104.001164_bib18","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1016\/S0006-2952(99)00054-4","article-title":"Unchanged cytochrome P450 3A (CYP3A) expression and metabolism of midazolam, triazolam and dexamethasone in mdr (-\/-) mouse liver microsomes.","volume":"57","author":"Perloff","year":"1999","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/dmd.104.001164_bib19","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1038\/clpt.1985.235","article-title":"Polymorphic dextromethorphan metabolism: co-segregation of oxidative O-demethylation with debrisoquin hydroxylation.","volume":"38","author":"Schmid","year":"1985","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/dmd.104.001164_bib20","first-page":"860","article-title":"Valepotriates and valerenic acids in commercial preparations of valerian available in Australia.","volume":"56","author":"Shohet","year":"2001","journal-title":"Pharmazie"},{"key":"10.1124\/dmd.104.001164_bib21","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1007\/BF00431449","article-title":"Pharmacokinetics and pharmacodynamics of alprazolam after oral and IV administration.","volume":"84","author":"Smith","year":"1984","journal-title":"Psychopharmacology"},{"key":"10.1124\/dmd.104.001164_bib22","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S1389-9457(99)00015-5","article-title":"Valerian for insomnia: a systematic review of randomized clinical trials.","volume":"1","author":"Stevinson","year":"2000","journal-title":"Sleep Med"},{"key":"10.1124\/dmd.104.001164_bib23","series-title":"Metabolic Drug Interactions","first-page":"115","article-title":"CYP3A","author":"Wrighton","year":"2000"},{"key":"10.1124\/dmd.104.001164_bib24","series-title":"Metabolic Drug Interactions","first-page":"87","article-title":"CYP2D6","author":"Zanger","year":"2000"},{"key":"10.1124\/dmd.104.001164_bib25","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1038\/clpt.1992.77","article-title":"Dextromethorphan: enhancing its systemic availability by way of low-dose quinidine-mediated inhibition of cytochrome P4502D6.","volume":"51","author":"Zhang","year":"1992","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/dmd.104.001164_bib26","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1016\/S0024-3205(02)01913-6","article-title":"Effects of herbal components on cDNA-expressed cytochrome P450 enzyme catalytic activity.","volume":"71","author":"Zou","year":"2002","journal-title":"Life Sci"}],"container-title":["Drug Metabolism and Disposition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624030381?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624030381?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/dmd.104.001164","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T17:01:47Z","timestamp":1739898107000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090955624030381"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,12]]},"references-count":26,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2004,12]]}},"alternative-id":["S0090955624030381"],"URL":"https:\/\/doi.org\/10.1124\/dmd.104.001164","relation":{},"ISSN":["0090-9556"],"issn-type":[{"value":"0090-9556","type":"print"}],"subject":[],"published":{"date-parts":[[2004,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"MULTIPLE NIGHT-TIME DOSES OF VALERIAN (Valeriana officinalis) HAD MINIMAL EFFECTS ON CYP3A4 ACTIVITY AND NO EFFECT ON CYP2D6 ACTIVITY IN HEALTHY VOLUNTEERS","name":"articletitle","label":"Article Title"},{"value":"Drug Metabolism and Disposition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/dmd.104.001164","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2004 The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}